Detalhe da pesquisa
1.
IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?
Biologicals
; 71: 55-60, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966960
2.
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation.
BMC Immunol
; 19(1): 6, 2018 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29386070
3.
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework.
Clin Infect Dis
; 73(4): e1011-e1017, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493317
4.
A Practical Guide to Full Value of Vaccine Assessments.
Vaccines (Basel)
; 12(2)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400184
5.
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
J Infect Dis
; 215(2): 167-170, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28073859
6.
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report.
Vaccine
; 41(49): 7307-7312, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37949751
7.
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Expert Opin Drug Deliv
; 20(3): 315-322, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36649573
8.
Therapeutic antibodies for infectious diseases.
Bull World Health Organ
; 95(3): 235-237, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28250538
9.
Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030.
Vaccine
; 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529593
10.
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
PLoS One
; 17(10): e0274943, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36256646
11.
Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvants.
Subcell Biochem
; 53: 303-21, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20593273
12.
Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?
Euro Surveill
; 21(38)2016 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27684999
13.
Author's reply: Regarding the editorial by Penttinen and Friede.
Euro Surveill
; 21(40)2016 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27748253
14.
Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba.
J Infect Dis
; 201(9): 1344-52, 2010 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20350164
15.
Seasonal influenza vaccination policies in the 194 WHO Member States: The evolution of global influenza pandemic preparedness and the challenge of sustaining equitable vaccine access.
Vaccine X
; 8: 100097, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34041476
16.
Evolving pharmacovigilance requirements with novel vaccines and vaccine components.
BMJ Glob Health
; 6(Suppl 2)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011500
17.
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.
Vaccine
; 39(45): 6573-6584, 2021 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34602302
18.
Tracking progress in universal influenza vaccine development.
Curr Opin Virol
; 40: 28-36, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279026
19.
HIV immunoprophylaxis: preparing the pathway from proof of concept to policy decision and use.
Lancet HIV
; 7(2): e141-e148, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786175
20.
H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets.
NPJ Vaccines
; 5(1): 38, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32411401